A drug with the SMILES COc1ccc(N2C(=O)C(CC(=O)Nc3ccc(Cl)cc3)N(NC(=O)c3cccc(F)c3)C2=S)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 14.650\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
COc1ccc(N2C(=O)C(CC(=O)Nc3ccc(Cl)cc3)N(NC(=O)c3cccc(F)c3)C2=S)cc1
COc1ccc(N2C(=O)C(CC(=O)Nc3ccc(Cl)cc3)N(NC(=O)c3cccc(F)c3)C2=S)cc1
N-[4-[2-(4-chloroanilino)-2-oxoethyl]-1-(4-methoxyphenyl)-5-oxo-2-sulfanylideneimidazolidin-3-yl]-5-fluorobenzamide